Skip to content

Comparing traditional Placement With placement using electrocArdiography for central Vascular access dEvices trial (P Wave Trial)

A randomised controlled trial of intracavitary electrocardiography versus traditional anthropometric guidance for central venous access device placement

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000919910
Acronym
P Wave Trial
Enrollment
344
Registered
2020-09-17
Start date
2016-12-13
Completion date
2018-07-04
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

It is hypothesised that inserting a central venous access devices (CVAD) using intra-cavitary electrocardiography (IC ECG) compared to traditional anthropometric guided insertion is more accurate resulting in shorter procedure times, less catheter malpositions and cost savings. CVAD malposition can lead to significant patient injury including heart rhythm disturbances, vessel or heart wall erosion or significant thrombosis. The aim of this study was to compare the IC ECG method for CVAD insertion with traditional CVAD placement in a broad patients population.

Interventions

This was a pragmatic, open-label randomised controlled trial comparing accuracy, timing and cost between anthropometric and intracavitary electrocardiography (IC ECG) guided CVAD insertion. Recruitment commenced 13th of December 2016 and completed 4th July 2018 with all patient follow completed by 10th September 2018. Ethical approval to commence this study was given by the South Western Sydney Local Health District Human Research Ethics Committee (HREC/15/LPOOL/552). CVAD insertion was per

This was a pragmatic, open-label randomised controlled trial comparing accuracy, timing and cost between anthropometric and intracavitary electrocardiography (IC ECG) guided CVAD insertion. Recruitment commenced 13th of December 2016 and completed 4th July 2018 with all patient follow completed by 10th September 2018. Ethical approval to commence this study was given by the South Western Sydney Local Health District Human Research Ethics Committee (HREC/15/LPOOL/552). CVAD insertion was performed by accredited nurses in both groups as a once off procedure (approximately 12 minutes). Maximal sterile technique with the use of ultrasound was used to gain venous access and to scan vessels during the procedure for suspected malposition. In the intervention group a portable, wireless IC-ECG navigation system (Nautilus Delta Tip Confirmation System– BARD Access Systems, Salt Lake City USA) was used to monitor changing R wave progression as well as increasing amplitude of the P wave to confirm position. When maximum P wave amplitude was achieved, the catheter tip was deemed to be located at the cavo-atrial junction (CAJ) or upper RA and the CVAD was then secured and dressed. This particular IC-ECG read out device was already established and has been used across hospitals in Europe. Training for users was provided by a local distributor and incorporated a blended learning approach with web based material and practical demonstration. Safety monitoring for this study was undertaken using local organisational governance procedures (documenting, escalating and reviewing any procedural or latent complications). Due to the low risk nature of the trial, no stopping rules were implemented as part of the study protocol. In both groups, a chest x ray (CXR) was administered post catheter insertion to confirm final catheter tip position. A single radiologist, (blinded to study group) with extensive experience in CXR film interpretation, reviewed all CXRs to confirm catheter tip position using digital calipers and the tracheal carina as a measuring landmark on the computerised film. Care and maintenance of devices in both groups was based on current hospital guidelines and was not distinguished. An independent observer documented the procedural time start time (first needle puncture of skin) and conclusion time (the sterile dressing was applied). Procedure room set up and clean up time was not included in timings. Although post procedure CXRs were performed in both groups, total procedure time was measured in the IC ECG group when sterile dressing was applied to skin, since this is when the catheter would normally be released for use after ECG confirmation. If catheters required repositioning after CXR in either group, time was measured for this additional procedure and added to the total procedure time.

Sponsors

Liverpool Hospital Australia
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria were: age of at least 18 years, a native P wave on ECG and ability to provide written informed consent in English

Exclusion criteria

Exclusion criteria were: patients less than 18 years, pacemaker dependency or no native P wave on ECG or inability to provide informed consent for themselves or via a responsible person.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 12, 2026